Skip to main content
OpenTrials

Clinical trial condition

Tardive Dyskinesia

Explore clinical trials studying Tardive Dyskinesia. Study availability and eligibility vary by location and protocol.

34 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Tardive Dyskinesia trial results

Recruiting

Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia

NCT07365462

Conditions
Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
Locations
  • Neurocrine Clinical Site Bryant, Arkansas, United States
  • Neurocrine Clinical Site Chino, California, United States
  • Neurocrine Clinical Site Fountain Valley, California, United States
  • Neurocrine Clinical Site Huntington Beach, California, United States
View all 18 locations
View Trial Details
Recruiting

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

NCT07105111

Conditions
Bipolar Disorder, Bipolar and Related Disorders, Central Nervous System Diseases, +17 more
Locations
  • Neurocrine Clinical Site Bryant, Arkansas, United States
  • Neurocrine Clinical Site Chino, California, United States
  • Neurocrine Clinical Site Fountain Valley, California, United States
  • Neurocrine Clinical Site Fresno, California, United States
View all 22 locations
View Trial Details
Completed

Addressing Involuntary Movements in Tardive Dyskinesia

NCT02291861

Conditions
Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
Locations
  • Teva Investigational Site 145 Tuscaloosa, Alabama, United States
  • Teva Investigational Site 107 Anaheim, California, United States
  • Teva Investigational Site 108 Anaheim, California, United States
  • Teva Investigational Site 123 Glendale, California, United States
View all 106 locations
View Trial Details
Completed

Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia

NCT05859698

Conditions
Bipolar Disorder, Bipolar and Related Disorders, Central Nervous System Diseases, +17 more
Locations
  • Neurocrine Clinical Site Bryant, Arkansas, United States
  • Neurocrine Clinical Site Anaheim, California, United States
  • Neurocrine Clinical Site Orange, California, United States
  • Neurocrine Clinical Site Torrance, California, United States
View all 18 locations
View Trial Details

Related conditions